LifeMD, Inc.: Form 10-Q for the period ended Jun 30, 2016
Filed with the SEC on Aug 15, 2016 and accepted by EDGAR at Aug 15, 2016, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-03-31 to 2016-06-30 | $1.2m | us-gaap:Revenues |
| Revenue | 6 months2016-01-01 to 2016-06-30 | $2.9m | us-gaap:Revenues |
| Cost of revenue | 3 months2016-03-31 to 2016-06-30 | $701.0k | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2016-01-01 to 2016-06-30 | $2.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2016-03-31 to 2016-06-30 | $526.3k | us-gaap:GrossProfit |
| Gross profit | 6 months2016-01-01 to 2016-06-30 | $829.4k | us-gaap:GrossProfit |
| Operating income | 3 months2016-03-31 to 2016-06-30 | −$153.6k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2016-01-01 to 2016-06-30 | −$258.7k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-03-31 to 2016-06-30 | $2.8k | us-gaap:InterestExpense |
| Interest expense | 6 months2016-01-01 to 2016-06-30 | $5.8k | us-gaap:InterestExpense |
| Net income | 3 months2016-03-31 to 2016-06-30 | −$200.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months2016-01-01 to 2016-06-30 | −$262.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-03-31 to 2016-06-30 | $32338946.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2016-01-01 to 2016-06-30 | $32174661.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-03-31 to 2016-06-30 | $32338946.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2016-01-01 to 2016-06-30 | $32174661.00 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 6 months2016-01-01 to 2016-06-30 | −$76.7k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2016-06-30 | $235.5k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-06-30 | $865.8k | us-gaap:AssetsCurrent |
| Total assets | At period end2016-06-30 | $865.8k | us-gaap:Assets |
| Current liabilities | At period end2016-06-30 | $521.6k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2016-06-30 | $278.2k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-16-016025. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.